Related Experiment Video
Updated: Apr 17, 2026
Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
The relation between α-synuclein and microglia in Parkinson's disease: Recent developments
V Sanchez-Guajardo1, N Tentillier2, M Romero-Ramos2
1AU IDEAS center NEURODIN, Aarhus University, DK-8000 Aarhus C, Denmark; Neuroimmunology of Degenerative Disease, Department of Biomedicine, Aarhus University, DK-8000 Aarhus C, Denmark.
Abstract:
Recent research suggests a complex role for microglia not only in Parkinson's disease but in other disorders involving alpha-synuclein aggregation, such as multiple system atrophy. In these neurodegenerative processes, the activation of microglia is a common pathological finding, which disturbs the homeostasis of the neuronal environment otherwise maintained, among others, by microglia. The term activation comprises any deviation from what otherwise is considered normal microglia status, including cellular abundance, morphology or protein expression. The microglial response during disease will sustain survival or otherwise promote cell degeneration. The novel concepts of alpha-synuclein being released and uptaken by neighboring cells, and their importance in disease progression, positions microglia as the main cell that can clear and handle alpha-synuclein efficiently. Microglia's behavior will therefore be a determinant on the disease's progression. For this reason we believe that the better understanding of microglia's response to alpha-synuclein pathological accumulation across brain areas and disease stages is essential to develop novel therapeutic tools for Parkinson's disease and other alpha-synucleinopathies. In this review we will revise the most recent findings and developments with regard to alpha-synuclein and microglia in Parkinson's disease.
Insights
Microglia play a crucial role in Parkinson's disease and other alpha-synucleinopathies. Understanding microglia's response to alpha-synuclein is key to developing new therapies.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Microglia activation is a common pathological finding in neurodegenerative diseases like Parkinson's disease (PD) and multiple system atrophy (MSA).
- Microglia maintain neuronal homeostasis, but their activation during disease can promote degeneration.
- Alpha-synuclein aggregation is central to PD and related disorders, with microglia being key players in its clearance.
Purpose of the Study:
- To review recent findings on the role of microglia in Parkinson's disease and other alpha-synucleinopathies.
- To highlight the importance of understanding microglia's response to alpha-synuclein accumulation.
- To explore the therapeutic potential of targeting microglia in neurodegenerative diseases.
Main Methods:
- Literature review of recent research on microglia and alpha-synuclein.
- Analysis of studies examining microglial activation in Parkinson's disease and related disorders.
- Synthesis of current knowledge on alpha-synuclein clearance by microglia.
Main Results:
- Microglia exhibit complex responses to alpha-synuclein, influencing disease progression.
- Microglia are central to the handling and clearance of extracellular alpha-synuclein.
- Microglial behavior significantly impacts neuronal survival or degeneration in alpha-synucleinopathies.
Conclusions:
- A deeper understanding of microglia's interaction with alpha-synuclein is essential for therapeutic development in PD and other alpha-synucleinopathies.
- Targeting microglial responses to pathological alpha-synuclein offers a promising therapeutic avenue.
- Further research into microglia's role across different disease stages and brain areas is warranted.
More Related Videos
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
08:33Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
Published on: June 25, 2019
Related Concept Videos
01:37Neural Regulation
01:15Parkinson's Disease: Overview